FDA Drug Recalls

Recalls / Class III

Class IIID-910-2013

Product

Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid) chewable tablets, 500 mg/200 mg, Cherry flavor, 65-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON L5N 2X7, foreign labeling containing English and French, NPN 80000899, UPC 0 58478 10090 6.

Affected lot / code info
Lot #: 10114318, Exp 01/14

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Recalling firm

Firm
Novartis Consumer Health
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
10401 Hwy 6, N/A, Lincoln, Nebraska 68517-9626

Distribution

Quantity
11,760 bottles
Distribution pattern
Nationwide, Canada, and Panama.

Timeline

Recall initiated
2013-08-06
FDA classified
2013-08-20
Posted by FDA
2013-08-28
Terminated
2014-11-04
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-910-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.